FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 268 filers reported holding FATE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $705,771 | -54.4% | 332,911 | +22.7% | 0.00% | -66.7% |
Q1 2023 | $1,546,974 | +158.3% | 271,399 | +1658.0% | 0.00% | +200.0% |
Q1 2022 | $599,000 | -61.8% | 15,438 | -42.5% | 0.00% | -66.7% |
Q4 2021 | $1,570,000 | -26.7% | 26,831 | -25.7% | 0.00% | -25.0% |
Q3 2021 | $2,142,000 | -35.3% | 36,132 | -5.2% | 0.00% | -33.3% |
Q2 2021 | $3,309,000 | +18.6% | 38,124 | +12.6% | 0.01% | +20.0% |
Q1 2021 | $2,791,000 | -13.1% | 33,847 | -4.2% | 0.01% | -16.7% |
Q4 2020 | $3,212,000 | +98.4% | 35,322 | -12.8% | 0.01% | +100.0% |
Q3 2020 | $1,619,000 | -4.7% | 40,506 | -18.1% | 0.00% | 0.0% |
Q2 2020 | $1,698,000 | +45.6% | 49,485 | -5.7% | 0.00% | +50.0% |
Q1 2020 | $1,166,000 | +211.8% | 52,479 | +175.0% | 0.00% | – |
Q4 2019 | $374,000 | -18.5% | 19,086 | -35.5% | 0.00% | -100.0% |
Q3 2019 | $459,000 | -24.6% | 29,579 | -1.3% | 0.00% | 0.0% |
Q2 2019 | $609,000 | +2.7% | 29,982 | -11.2% | 0.00% | 0.0% |
Q1 2019 | $593,000 | +19.1% | 33,772 | -13.0% | 0.00% | 0.0% |
Q4 2018 | $498,000 | -35.2% | 38,814 | -17.8% | 0.00% | 0.0% |
Q3 2018 | $769,000 | +43.7% | 47,207 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $535,000 | +70.9% | 47,207 | +47.4% | 0.00% | – |
Q1 2018 | $313,000 | – | 32,037 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |